OMB Control No: 0920-0978
ICR Reference No:
202505-0920-009
Status: Received in OIRA
Previous ICR Reference No: 202504-0920-028
Agency/Subagency: HHS/CDC
Agency Tracking No:
0920-25-0122
Title: [NCEZID] Emerging Infections
Program
Type of Information Collection: No
material or nonsubstantive change to a currently approved
collection
Common Form ICR: No
Type of Review Request: Regular
Date Submitted to OIRA:
06/03/2025
Requested
Previously Approved
Expiration Date
09/30/2027
09/30/2027
Responses
88,158
88,158
Time Burden (Hours)
40,013
40,013
Cost Burden (Dollars)
0
0
Abstract: The Emerging Infections Programs (EIP)
is to 1) detect and monitor emerging pathogens, the diseases they
cause, and the factors influencing their emergence, and respond to
problems as they are identified, 2) integrate laboratory science
and epidemiology to optimize public health practice, 3) strengthen
infrastructure to support surveillance and research and to
implement prevention and control programs, and to 4) ensure
implementation of prevention strategies and communication of public
health information about emerging diseases. Surveillance efforts of
the core EIP activities generate reliable estimates of the
incidence of certain infections and provide the foundation for a
variety of epidemiologic studies. This Non-Substantive Change
Request is submitted to make minor modifications to approved
instruments including revised formatting, rewording, new answer
options, and the addition/subtraction of a limited number of
questions. There is no anticipated change to the approved burden
hours.
Authorizing Statute(s): US Code:
42
USC 301 Name of Law: Public Health Service Act
Citations for New Statutory
Requirements: None
Associated Rulemaking
Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices &
Comments
60-day Notice:
Federal Register Citation:
Citation Date:
89 FR
14501
02/27/2024
30-day Notice:
Federal Register Citation:
Citation Date:
89 FR
58736
07/19/2024
Did the Agency receive public comments on
this ICR? No
Number of Information Collection (IC) in this
ICR: 32
IC Title
Form No.
Form Name
(MuGSI)
Healthcare-Associated Infections Community Interface (HAIC) Case
Report
HAIC 400.1, HAIC 400.1, HAIC 400.1
2024 Multi-site
Gram-Negative Surveillance Initiative (MuGSI) Healthcare-Associated
Infections Community Interface (HAIC) Case Report_rev 2025 ,
2025 Multi-site
Gram-Negative Surveillance Initiative (MuGSI) Healthcare-Associated
Infections Community Interface (HAIC) Case Report _rev 2025 ,
HAIC.400.1
Multi-Site Gram-Negative Surveillance Initiative (MuGSI) Case
Report Form - 2026
2019 ABCs H.
Influenzae Neonatal Sepsis Expanded Surveillance Form
ABC.100.3
2019 ABC H.
Influenzae Neonatal Sepsis Expanded Surveillance Form
2024 Active Bacterial
Core Surveillance (ABCs) Case Report
ABC.100.1, ABC 100.1
2024 Active
Bacterial Core Surveillance (ABCs) Case Report ,
2025 Active Bacterial
Core Surveillance (ABCs) Case Report
ABCs Invasive
Pneumococcal Disease in Children and Adults
ABC.100.2, ABC 100.2
ACTIVE BACTERIAL
CORE SURVEILLANCE (ABCs) INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN
(aged ≥2 months to <5 years) AND ADULTS (aged ≥65 years) ,
2025 ACTIVE
BACTERIAL CORE SURVEILLANCE (ABCs) INVASIVE PNEUMOCOCCAL DISEASE IN
CHILDREN (aged ≥2 months to <5 years) AND ADULTS (aged ≥65
years)
ABCs Severe GAS
Infection: Supplemental Form
ABC.100.4
ABCs Severe GAS
Infection: Supplemental Form
Active Bacterial Core
Surveillance (ABCs) Neonatal Infection Expanded Tracking
Form
ABC.100.5, ABC 100.5
ACTIVE BACTERIAL
CORE SURVEILLANCE (ABCs) NEONATAL INFECTION EXPANDED TRACKING
FORM , 2025
ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) NEONATAL INFECTION
EXPANDED TRACKING FORM
Annual Survey of
Laboratory Testing Practices for C. difficile Infection
HAIC.400.8, HAIC 400.8, HAIC 400.8
Annual Survey of
Laboratory Testing Practices for C. difficile Infection ,
Annual Survey
of Laboratory Testing Practices for C. difficile Infection ,
HAIC.400.8
Annual Survey of Laboratory Testing Practices for C. difficile
Infections - 2026
CANDIDEMIA 2024 CASE
REPORT FORM
HAIC 400.11, HAIC 400.11
CANDIDEMIA 2024
CASE REPORT FORM_rev 2025 , CANDIDEMIA 2025 CASE REPORT
FORM_rev 2025
CDC's
Healthcare-Associated Infections Community Interface (HAIC)
Staphylococcus aureus 2024 Laboratory Survey
HAIC.400.5
CDC’s
Healthcare-Associated Infections Community Interface (HAIC)
Staphylococcus aureus 2024 Laboratory Survey
CLOSTRIDIOIDES
DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM
CASE REPORT
HAIC 400.7, HAIC 400.7, HAIC 400.7
2024
CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING
INFECTIONS PROGRAM CASE REPORT_rev 2025 , 2025 CLOSTRIDIOIDES DIFFICILE
INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE
REPORT_ rev 2025 , HAIC.400.7 CDI Case Report and
Treatment Form - 2026
Community-Associated
CP-CRE Interview
HAIC.400.2
Community-Associated CP-CRE
Interview
Data Elements
Transferred to CDC for the HAIC Death Ascertainment
Project
HAIC.400.13
Data Elements
Transferred to CDC for the HAIC Death Ascertainment
Project
Emerging Infections
Program C. difficile Surveillance Nursing Home Telephone
Survey
HAIC.400.10
Emerging
Infections Program C. difficile Surveillance Nursing Home Telephone
Survey
FLUSURV-NET: CONSENT
FORM FOR PATIENT/PROXY INTERVIEW (English/Spanish)
FSN.300.2
FLUSURV-NET:
CONSENT FORM FOR PATIENT/PROXY INTERVIEW
FLUSURV-NET: PROVIDER
PEDIATRIC VACCINATION HISTORY REQUEST LETTER/FORM
FSN.300.3
FLUSURV-NET:
PROVIDER PEDIATRIC VACCINATION HISTORY REQUEST LETTER/FORM
FluSurv-NET Laboratory
Survey 2023–2024 Season
FSN.300.4
FluSurv-NET
Laboratory Survey 2023–2024 Season
FluSurv-Net Influenza
Hospitalization Surveillance Network Case Report Form
FSN.300.1, FSN 300.1
Influenza
Hospitalizatin Surveillance Network (FluSurv-NET) Case Report
Form , 2024-25 Influenza
Hospitalization Surveillance Network (FluSurv-NET) Case Report
Form
FoodNET Lab Survey
Variable List 2024
FN.200.10
FoodNET Lab Survey
Variable List, 2024
FoodNet Hemolytic
Uremic Syndrome (HUS)
ABC 200.9
FoodNet CDC's
FoodNet Hemolytic Uremic Syndrome (HUS) Surveillance Case Report
Form_rev 2025
FoodNet Variable List,
2024_ (CYCLOSPORA)
FN200.2, FN.200.2, FN 200.2
FoodNet Variable
List, 2024_ (CYCLOSPORA) , FoodNet Variable List,
(Site-transmitted variables) - 2025 , FN200.1-200.8_FoodNet Variable
List_2026
FoodNet Variable List,
2024_ (LISTERIA MONOCTOGENES)
FN200.3, FN.200.3, FN 200.3
FoodNet Variable
List, 2024_ (LISTERIA MONOCYTOGENES) , FoodNet Variable List,
(Site-transmitted variables) - 2025 , FN200.1-200.8_FoodNet Variable
List_2026
FoodNet Variable List,
2024_ (SALMONELLA)
FN200.4, FN.200.4, FN 200.4
FoodNet Variable
List, 2024_ (SALMONELLA) , FoodNet Variable List,
(Site-transmitted variables) - 2025 , FN200.1-200.8_FoodNet Variable
List_2026
FoodNet Variable List,
2024_ (SHIGA TOXIN PRODUCING E.COLI)
FN200.5, FN.200.5, FN 200.5
FoodNet Variable
List, 2024_ (SHIGA TOXIN PRODUCING E.COLI) , FoodNet Variable List,
(Site-transmitted variables) - 2025 , FN200.1-200.8_FoodNet Variable
List_2026
FoodNet Variable List,
2024_ (SHIGELLA)
FN200.6, FN.200.6, FN 200.6
FoodNet Variable
List, 2024_ (SHIGELLA) , FoodNet Variable List,
(Site-transmitted variables) - 2025 , FN200.1-200.8_FoodNet Variable
List_2026
FoodNet Variable List,
2024_ (VIBRIO)
FN200.7, FN.200.7, FN 200.7
FoodNet Variable
List, 2024_ (VIBRIO) , FoodNet Variable List,
(Site-transmitted variables) - 2025 , FN200.1-200.8_FoodNet Variable
List_2026
FoodNet Variable List,
2024_ (YERSINIA)
FN200.8, FN.200.8, FN 200.8
FoodNet Variable
List, 2024_ (YERSINIA) , FoodNet Variable List,
(Site-transmitted variables) - 2025 , FN200.1-200.8_FoodNet Variable
List_2026
FoodNet Variable List,
2024_(CAMPYLOBACTER)
FN200.1, FN.200.1, FN 200.1
FoodNet Variable
List, 2024_ (CAMPYLOBACTER) , FoodNet Variable List,
(Site-transmitted variables) - 2025 , FN200.1-200.8_FoodNet Variable
List_2026
HAIC Invasive
Staphylococcus aureus Supplemental Surveillance Officer
Survey
HAIC.400.6, HAIC 400.6, HAIC 400.6
2023 HAIC Invasive
Staphylococcus aureus Supplemental Surveillance Officer Survey
, 2024 HAIC
Invasive Staphylococcus aureus Supplemental Surveillance Officer
Survey , HAIC.400.6 HAIC Invasive
Staphylococcus aureus Supplemental Surveillance Officer Survey -
2026
HAIC Multi-site
Gram-negative Surveillance Initiative (MuGSI) Supplemental
Surveillance Officer Survey
HAIC.400.3, HAIC 400.3
2024 HAIC
Multi-site Gram-negative Surveillance Initiative (MuGSI)
Supplemental Surveillance Officer Survey , HAIC.400.3–HAIC MuGSI
Supplemental Surveillance Officer Survey - 2026
HAIC-Surveillance
Officer's Survey
HAIC.400.9, HAIC 400.9, HAIC 400.9
HAIC Surveillance
Officer’s Survey , HAIC Surveillance Officer’s
Survey , HAIC.400.9 CDI Annual
Surveillance Officers Survey - 2026
HAIC_LABORATORY
TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE
HAIC.400.12, HAIC 400.12
2024 LABORATORY
TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE ,
2025 LABORATORY
TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE
Invasive
Staphylococcus aureus Healthcare-Associated Infections Community
Interface (HAIC) Case Report
HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4,
HAIC 400.4, HAIC 400.4
2024 Invasive
Staphylococcus aureus Healthcare-Associated Infections Community
Interface (HAIC) Case Report_rev 2025 , 2025 Invasive Staphylococcus
aureus Healthcare-Associated Infections Community Interface (HAIC)
Case Report_rev 2025 , 2022 Invasive
Methicillin-Resistant Staphylococcus aureus Healthcare-Associated
Infections Community Interface (HAIC) Case Report _rev 2025 ,
2023 Invasive
Methicillin-Resistant Staphylococcus aureus Healthcare-Associated
Infections Community Interface (HAIC) Case Report _rev 2025 ,
2022 Invasive
Methicillin-Sensitive Staphylococcus aureus Healthcare-Associated
Infections Community Interface (HAIC) Case Report _rev 2025 ,
2023 Invasive
Methicillin-Sensitive Staphylococcus aureus Healthcare-Associated
Infections Community Interface (HAIC) Case Report _rev 2025 ,
HAIC.400.4
Invasive Staphylococcus aureus HAIC Case Report - 2026
ICR Summary of Burden
Total Request
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in
Estimate
Change Due to Potential Violation of
the PRA
Annual Number of Responses
88,158
88,158
0
0
0
0
Annual Time Burden (Hours)
40,013
40,013
0
0
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency
Discretion: No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency
Discretion: No
Burden Reduction Due to:
Short Statement:
Annual Cost to Federal Government:
$41,699,051
Does this IC contain surveys, censuses, or employ
statistical methods? Yes Part B of Supporting Statement
Does this ICR request any personally identifiable
information (see OMB Circular No. A-130 for an
explanation of this term)? Please consult with your agency's
privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act
Statement (see 5
U.S.C. §552a(e)(3) )? Please consult with your agency's privacy
program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L.
111-148 & 111-152]? No
Is this ICR related to the Dodd-Frank Wall Street Reform
and Consumer Protection Act, [Pub. L. 111-203]? No
Is this ICR related to the American Recovery and
Reinvestment Act of 2009 (ARRA)? No
Is this ICR related to the Pandemic Response?
No
Agency Contact: Jeffrey Zirger 404 639-7118
wtj5@cdc.gov